| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,529 |
19,289 |
$1.81M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,899 |
5,585 |
$699K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,252 |
5,150 |
$551K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,656 |
4,533 |
$487K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,785 |
3,731 |
$434K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,012 |
2,823 |
$293K |
| 92552 |
|
9,906 |
9,699 |
$251K |
| 90686 |
|
5,686 |
5,573 |
$122K |
| D1206 |
Topical application of fluoride varnish |
3,502 |
3,481 |
$88K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,002 |
4,856 |
$80K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,472 |
2,438 |
$55K |
| 90670 |
|
2,173 |
2,098 |
$49K |
| 96127 |
|
4,942 |
4,849 |
$44K |
| 90651 |
|
1,798 |
1,769 |
$44K |
| 99177 |
|
8,435 |
8,262 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,733 |
1,509 |
$39K |
| 90680 |
|
1,712 |
1,661 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,797 |
2,661 |
$37K |
| 90633 |
|
1,591 |
1,554 |
$34K |
| 90734 |
|
1,451 |
1,415 |
$34K |
| 90647 |
|
1,582 |
1,521 |
$32K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,546 |
3,495 |
$31K |
| 90620 |
|
1,016 |
994 |
$28K |
| 90723 |
|
1,190 |
1,152 |
$26K |
| 90677 |
|
412 |
403 |
$23K |
| 2015F |
|
1,099 |
1,074 |
$20K |
| 90710 |
|
735 |
719 |
$18K |
| 90697 |
|
489 |
484 |
$18K |
| 90700 |
|
775 |
752 |
$16K |
| 92551 |
|
1,606 |
1,574 |
$15K |
| W7000 |
|
2,687 |
2,639 |
$14K |
| 90715 |
|
612 |
597 |
$14K |
| 90696 |
|
589 |
577 |
$13K |
| 97802 |
|
505 |
497 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
285 |
277 |
$11K |
| 90716 |
|
509 |
495 |
$11K |
| 90656 |
|
463 |
460 |
$10K |
| 90707 |
|
503 |
489 |
$10K |
| 99173 |
|
3,717 |
3,659 |
$9K |
| 94760 |
|
4,299 |
3,914 |
$9K |
| 86580 |
|
1,008 |
980 |
$7K |
| 0001A |
|
156 |
156 |
$6K |
| 99381 |
|
59 |
56 |
$6K |
| 0002A |
|
130 |
130 |
$5K |
| 96160 |
|
1,934 |
1,901 |
$5K |
| 90661 |
|
158 |
158 |
$5K |
| 96161 |
|
1,693 |
1,616 |
$4K |
| 3008F |
|
795 |
792 |
$3K |
| 99050 |
|
170 |
168 |
$2K |
| 90672 |
|
86 |
84 |
$2K |
| 90688 |
|
139 |
133 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
72 |
71 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
13 |
13 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
26 |
26 |
$1K |
| 99058 |
|
57 |
56 |
$632.85 |
| 3011F |
|
63 |
63 |
$620.00 |
| 90713 |
|
28 |
27 |
$588.13 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
76 |
71 |
$586.34 |
| 99051 |
|
47 |
47 |
$340.00 |
| 90744 |
|
12 |
12 |
$281.47 |
| 90687 |
|
16 |
14 |
$174.41 |
| 81002 |
|
58 |
56 |
$156.29 |
| 99000 |
|
65 |
62 |
$69.93 |
| 1005F |
|
15 |
15 |
$0.00 |